Global Animal Drug Compounding Market Size Study, by Product (Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, Others), by Animal Type (Companion Animal, Livestock), by Dosage Form (Capsules, Solutions, Powders, Suspension, Others), by Route of Administration (Oral, Injectable, Topical, Rectal, Ocular) and Regional Forecasts 2022-2032
The Global Animal Drug Compounding Market is valued at approximately USD 1.27 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2024-2032. Rapid advancements in pharmaceutical production techniques and the growth of the biotechnology industry have significantly benefited stakeholders in animal medicine compounding. The increasing awareness of animal health among pet owners and the unavailability of certain officially approved drugs have fueled the demand for veterinary medicine compounding. This trend is further supported by the rise in pet ownership and the subsequent approval of compounded medication practices among animal owners. Leading market players are increasingly focusing on strategic partnerships and collaborations to expand their global presence.
Animal drug compounding involves the customization of medications by combining, blending, or modifying ingredients to meet the specific needs of individual animals. These drugs, typically prepared by pharmacists or veterinarians, cater to various veterinary applications. Compounded animal drug companies are striving to ensure a steady supply of chemical compounds and materials, essential for supporting veterinary compounding practices. For instance, Letco Medical offers a formula database that aids in selecting the optimal combination for any animal, collaborating closely with API suppliers, base providers, and flavor formulators to support the production of animal drugs.
The rise in pet ownership has led to the growth of veterinary pharmacists who compound medications, avoiding common allergens found in animals and tailoring drugs to specific needs. Governments are supporting this trend by funding programs, fellowships, and grants to develop the necessary skills for medication compounding. In Europe, the EAHP is encouraging health authorities to facilitate the transfer of drug store preparations among hospitals and invest in compounding services to address extraordinary situations like essential medicine shortages.
The demand for companion animals has surged globally, driving the need for compounded medications tailored to their unique requirements. Compounded medications offer personalized treatment options for various animal species, making them more palatable and effective. This service is particularly beneficial for pets, as it allows for the addition of flavors and colors to improve medication acceptance. Farmers and ranchers also rely on compounded medicines to ensure the health of their livestock, protect public health, and safeguard the food supply.
The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. North America accounted for dominating position of the global market in 2023, supported by a well-established healthcare infrastructure and the rapid adoption of new therapeutic strategies. The U.S., in particular, is anticipated to maintain a major market share due to technological advancements in compounding machines. In Asia Pacific, the market is expected to grow fastest rate, driven by the increasing acceptance of compounded veterinary planning and a surge in pet ownership.
Key players in the global animal drug compounding market are
Wedgewood Pharmacy
Triangle Compounding Pharmacy
Davis Islands Pharmacy
Custom Med Compounding Pharmacy
Central Compounding Center South
Wellness Pharmacy of Cary
Caringbah Compounding Pharmacy
Millers Pharmacy
Smith's Pharmacy
Specialist Compounding Pharmacy Pte Ltd
Tache Pharmacy
Boehringer Ingelheim
Zoetis Inc.
Merck Animal Health
Bayer Animal Health
By Region:
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Years considered for the study are as follows:Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.